Gene expression markers for predicting response to chemotherapy

Details for Australian Patent Application No. 2005233593 (hide)

Owner Genomic Health, Inc. Fondazione IRCCS Istituto Nazionale Dei Tumori

Inventors Shak, Steven; Baker, Joffre B.; Gianni, Luca

Agent Griffith Hack

Pub. Number AU-B-2005233593

PCT Pub. Number WO2005/100606

Priority 60/561,035 09.04.04 US

Filing date 7 April 2005

Wipo publication date 27 October 2005

Acceptance publication date 26 August 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/100606 Priority application(s): WO2005/100606

26 August 2010 Application Accepted

  Published as AU-B-2005233593

23 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005233598-Method for De novo detection of sequences in nucleic acids:target sequencing by fragmentation

2005233591-Thioamide derivatives as progesterone receptor modulators